Navigation Links
Burrill & Company Announces Promotions
Date:1/4/2008

SAN FRANCISCO, Jan. 4 /PRNewswire/ -- Burrill & Company is pleased to announce the following promotions effectively immediately:

-- Mr. Bryant Fong to Managing Director -- Bryant joined Burrill in 1998

after working with two early stage companies as a biochemist and

molecular biologist. Bryant, a UC Berkeley graduate (with distinction

and honors) in Molecular and Cell Biology-Biochemistry, has served the

Venture arm of the company being involved in all phases of its growth.

-- Mr. Greg Young to Director -- Greg joined Burrill & Company in 2000 and

also worked as a molecular biologist for an early stage company before

joining Burrill. Greg received his BS degree from UC San Diego and his

Masters in Biotechnology from Northwestern University.

-- Tiba Aynechi to Senior Associate -- Tiba joined Burrill in 2006 after

serving as a post-doc at University of California San Francisco. She

received her PhD in Biophysics from UCSF and her undergraduate degree

from UC Irvine.

-- Jackie Tay to Associate -- Prior to joining the company in 2006 Ms. Tay

worked in the Healthcare Investment Banking Group at Lehman Brothers

and at Stanford's Office of Technology Licensing. She holds a B.S in

Biology from Cornell University.

"We are delighted announce these promotions, which are reflective of the dedication and commitment that these individuals have shown as our company continues to grow and serve the life sciences sector," said G. Steven Burrill, CEO, Burrill & Company, a San Francisco based global leader in life sciences with activities in Private Equity, Venture Capital, Merchant Banking and Media.


'/>"/>
SOURCE Burrill & Company
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. The 3rd Annual Burrill Personalized Medicine Meeting November 12-13, 2007 in San Francisco
2. Brazilian National Biosafety Technical Committee Approves Monsanto Company Insect-Protected Corn Trait
3. Spherix Shareholders Support Companys Focus on Naturlose, Biotechnology
4. Apria Healthcare Chooses Masimo SET Pulse Oximetry for Use in the Companys Home Health Care Business
5. Kendle Marks 10th Anniversary as Public Company With NASDAQ Opening Bell Ceremony and Investor Day Event
6. OncoVista, Inc. Closes on $6.8 Million Financing and Acquires Control of a Public Shell Company
7. Verenium Corporation to Present at the Upcoming Cowen and Company Clean Energy Conference
8. NASA technology forms the basis for a new nanotechnology company
9. Solazyme, Inc. Selected by AlwaysOn as a GoingGreen 100 Top Private Company Award Winner
10. Abaxis to Present at the Sidoti & Company Sixth Annual San Francisco Institutional Investor Forum Conference
11. Monsanto Company Signs Share Subscription Agreement With Devgen
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/16/2017)... ... August 16, 2017 , ... Recent ... cell type. Many treatments for specific cancers, such as breast, prostate, or lung, ... is androgen deprivation therapy for advanced prostate cancer. , This therapy limits ...
(Date:8/16/2017)... ... August 16, 2017 , ... Today, 3Bar ... has secured $2M in funding from an impressive group of investors, including Rev1 ... Thrive Fund. With this investment, 3Bar is broadening availability of its groundbreaking offering ...
(Date:8/16/2017)... edition of the Inc. 5000 features a now-familiar name: BioPoint ( http://biopointinc.com/ ... list for the third year in a row. Now in its 36th ... a set of quantitative metrics. In addition, BioPoint was also named to ... Bay State . ... ...
(Date:8/15/2017)... , Aug. 15, 2017 After spending the past ... support with crowdsourced data collection, GeneFo now offers this platform to ... aligning and amplifying support, adherence, and data collection vis a vis ... foundations mark the successful launch of this offer. ... GeneFo ...
Breaking Biology Technology:
(Date:4/5/2017)... -- KEY FINDINGS The global market for ... of 25.76% during the forecast period of 2017-2025. The ... the growth of the stem cell market. ... INSIGHTS The global stem cell market is segmented on ... stem cell market of the product is segmented into ...
(Date:4/3/2017)... , April 3, 2017  Data ... precision engineering platform, detected a statistically significant ... product prior to treatment and objective response ... the potential to predict whether cancer patients ... to treatment, as well as to improve ...
(Date:3/30/2017)... The research team of The Hong Kong ... identification by adopting ground breaking 3D fingerprint minutiae recovery and matching ... and accuracy for use in identification, crime investigation, immigration control, security ... ... A research team led by ...
Breaking Biology News(10 mins):